Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tímea Varjas is active.

Publication


Featured researches published by Tímea Varjas.


Phytotherapy Research | 2010

The effect of fenugreek on the gene expression of arachidonic acid metabolizing enzymes

Tímea Varjas; Ghodratollah Nowrasteh; Ferenc Budán; Gábor Horváth; József Cseh; Zoltán Gyöngyi; Sándor Makai; István Ember

The main bioactive compounds of Trigonella foenum graecum L. (fenugreek) seeds are protodioscin, trigoneoside, diosgenin and yamogenin, which have anticarcinogenic potency through inhibition of cell proliferation and inhibition of prostaglandin synthesis.


Phytotherapy Research | 2009

Chemopreventive Effect of Panax ginseng

Tímea Varjas; Ghodratollah Nowrasteh; Ferenc Budán; E. Nadasi; Gábor Horváth; Sándor Makai; Tünde Gracza; József Cseh; István Ember

Asian ginseng (Panax ginseng C. A. Meyer) has been used in Chinese medicine for two thousand years. The root of ginseng contains several saponins (ginsenosides) which are biologically active compounds. Individual ginsenosides suppress tumor cell growth, induce cell differentiation, regulate apoptosis and inhibit metastasis formation. The aim of this study was to evaluate its chemo‐preventive effects in an animal test model, through its regulatory effects on apoptosis and the cell cycle.


Phytotherapy Research | 2011

Mixtures of Uncaria and Tabebuia extracts are potentially chemopreventive in CBA/Ca mice: a long‐term experiment

Ferenc Budán; István Szabó; Tímea Varjas; Ghodratollah Nowrasteh; Tamás Dávid; Péter Gergely; Zsuzsa Varga; Kornélia Molnár; Balázs Kádár; Zsuzsa Orsós; István Kiss; István Ember

A long‐term experimental animal model was developed by our research group for the evaluation of potential chemopreventive effects. The inhibitory effects of agents on carcinogen (7,12‐dimethylbenz[a]anthracene (DMBA) induced molecular epidemiological biomarkers, in this case the expression of key onco/suppressor genes were investigated.


in Vivo | 2018

Expression of Circulating miR-155, miR-21, miR-221, miR-30a, miR-34a and miR-29a: Comparison of Colonic and Rectal Cancer

Enikő Orosz; István Kiss; Zoltán Gyöngyi; Tímea Varjas

Background: Colorectal cancer is an increasing cause of death. Circulating microRNAs (miRs) could be great diagnostic and prognostic biomarkers of colorectal cancer, but further continuation of their utility is needed for their comprehensive application. Materials and Methods: Twenty-seven patients with colonic cancer, 16 with rectal cancer and 12 healthy volunteers as controls, were involved in this study. Expression of miR-155, miR-21, miR-221, miR-30a, miR-34a and miR-29a were determined by reverse transcription polymerase chain reaction (RT-PCR) from sera of patients. Results: Expression of miR-155, miR-21 and miR-221 was significantly higher in rectal cancer than in colonic cancer. There was no difference found between those with TNM1 cancer and controls for both cancer types. miR-155, miR-34a and miR-29a were down-regulated in all patients with cancer compared to controls. We did not find any statistically significant up-regulation of miR-221 in patients with colonic cancer compared to controls. In contrast, in patients with rectal cancer, miR-221 expression was higher than in controls. Advanced stage was also linked to higher miR-221 expression compared to early stage. Slight, but statistically significant increase was observed in miR-30a expression in patients with colon cancer compared to control individuals. Conclusion: Our results partly support previous findings. Here we report on differences in the expression of circulating microRNA between colonic and rectal tumours for the first time.


Anticancer Research | 2009

Epigenetic modifiers exacerbate oxidative stress in renal proximal tubule cells.

Edit Nadasi; Jeb S. Clark; István Szanyi; Tímea Varjas; István Ember; Radhakrishna Baliga; Istvan Arany


in Vivo | 2009

Early Modification of c-myc, Ha-ras and p53 Expressions by Chemical Carcinogens (DMBA, MNU)

Ferenc Budán; Tímea Varjas; Ghodratollah Nowrasteh; Ida Prantner; Zsuzsa Varga; Ágoston Ember; József Cseh; Katalin Gombos; Emese Pázsit; Gyula Gobel; Miklós Bauer; Tünde Gracza; Istvan Arany; P. Á L Perjési; István Ember; István Kiss


in Vivo | 2008

Early modification of c-myc, Ha-ras and p53 expressions by N-methyl-N-nitrosourea.

Ferenc Budán; Tímea Varjas; Ghodratollah Nowrasteh; Zsuzsa Varga; I Boncz; József Cseh; Ida Prantner; Tibold Antal; Emese Pázsit; Gyula Gobel; Miklós Bauer; Tünde Gracza; Pál Perjési; István Ember; Zoltán Gyöngyi


in Vivo | 2007

The Effect of Aspartame Administration on Oncogene and Suppressor Gene Expressions

Katalin Gombos; Tímea Varjas; Zsuzsanna Orsós; Éva Polyák; Judit Peredi; Zsuzsanna Varga; Ghodratollah Nowrasteh; Antal Tettinger; Gyula Mucsi; István Ember


Cancer Genomics & Proteomics | 2007

Characterization of Microarray Gene Expression Profiles of Early Stage Thyroid Tumours

Katalin Gombos; Eszter Szele; István Kiss; Tímea Varjas; László G. Puskás; László Kozma; Ferenc Juhasz; Erik Kovács; István Szanyi; István Ember


in Vivo | 2005

Carcinogenic potential of trans-2-hexenal is based on epigenetic effect.

Edit Nádasi; Tímea Varjas; Lászloó Pajor; István Ember

Collaboration


Dive into the Tímea Varjas's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Istvan Arany

University of Mississippi

View shared research outputs
Researchain Logo
Decentralizing Knowledge